3.260SEK-1.81%Mkt Cap: 126.60M SEKP/E: —Last update: 2026-06-01
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap126.60M SEK
Enterprise Value332.43M SEK
Revenue (TTM)478.39M SEK
Gross Profit213.81M SEK
Net Income (TTM)-3.75M SEK
Revenue/Share12.30 SEK
Last Price3.260 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.94
PEG—
EV/EBITDA6.76
EV/Revenue0.69
P/S0.27
P/B0.75
EPS (TTM)-0.03
EPS (Forward)1.13
52W Range
3.1402% of range10.60
52W High10.60 SEK
52W Low3.140 SEK
Profitability
Gross Margin43.66%
Oper. Margin-1.38%
EBITDA Margin10.27%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-10.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF829.00K SEK
CapEx (TTM)4.96M SEK
FCF Margin3.86%
FCF Yield14.57%
Net Debt203.50M SEK
Net Debt/EBITDA4.14
Balance Sheet
Debt/Equity1.33
Current Ratio1.06
Quick Ratio0.69
Book Value/Sh4.416 SEK
Cash/Share0.4760 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield0.73%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating—
Target (Mean)3.800 SEK
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders38.56%
Institutions54.28%
Technical
SMA 503.698 (-11.8%)
SMA 2004.860 (-32.9%)
Beta0.17
S&P 52W Chg27.70%
Avg Vol (30d)52.33K
Avg Vol (10d)34.35K
Technical Indicators
RSI (14)42.3
MACD-0.0799
MACD Signal-0.1097
MACD Hist.+0.0298
BB Upper3.649 SEK
BB Middle3.392 SEK
BB Lower3.135 SEK
BB Width15.12%
ATR (14)0.1975 SEK
Vol Ratio (20d)1.29x